Rezolute Inc is trading 5.4% up today at $5.05, extending a strong multi-day rally from the low-$3 range following positive clinical data presentations.
- The move follows highlighted data from four new presentations regarding its hyperinsulinism program at the Endocrine Society (ENDO) annual meeting on June 17, 2026.
- Positive sentiment from the clinical updates continues to drive the stock higher, supported by a generally risk-on market backdrop.